| 000 | 01809 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516232452.0 | ||
| 264 | 0 | _c20150202 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1879-3169 | ||
| 024 | 7 |
_a10.1016/j.toxlet.2014.09.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWorek, Franz | |
| 245 | 0 | 0 |
_aPost-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study. _h[electronic resource] |
| 260 |
_bToxicology letters _cNov 2014 |
||
| 300 |
_a45-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetylcholinesterase _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntidotes _xadministration & dosage |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aCatalysis |
| 650 | 0 | 4 |
_aChemical Warfare Agents _xmetabolism |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xblood |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aErythrocytes _xdrug effects |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xblood |
| 650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xblood |
| 650 | 0 | 4 |
_aPhosphoric Triester Hydrolases _xadministration & dosage |
| 650 | 0 | 4 | _aProtein Engineering |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSeeger, Thomas | |
| 700 | 1 | _aReiter, Georg | |
| 700 | 1 | _aGoldsmith, Moshe | |
| 700 | 1 | _aAshani, Yacov | |
| 700 | 1 | _aLeader, Haim | |
| 700 | 1 | _aSussman, Joel L | |
| 700 | 1 | _aAggarwal, Nidhi | |
| 700 | 1 | _aThiermann, Horst | |
| 700 | 1 | _aTawfik, Dan S | |
| 773 | 0 |
_tToxicology letters _gvol. 231 _gno. 1 _gp. 45-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.toxlet.2014.09.003 _zAvailable from publisher's website |
| 999 |
_c24166078 _d24166078 |
||